5 results on '"arylpiperazines"'
Search Results
2. Development and challenges in the discovery of 5-HT 1A and 5-HT 7 receptor ligands.
- Author
-
Singh D, Singh P, Srivastava P, Kakkar D, Pathak M, and Tiwari AK
- Subjects
- Humans, Brain metabolism, Anxiety, Binding Sites, Ligands, Serotonin metabolism, Receptors, Serotonin metabolism
- Abstract
Serotonin (5-hydroxytryptamine) is a small molecule that acts both in the central and peripheral nervous system as a neurotransmitter and a hormone, respectively. Serotonin is synthesized via a multi-stage pathway beginning with l-tryptophan, which is converted by an enzyme called tryptophan hydroxylase into L-5-Hydroxytryptophan. It is well-known for its significance in the control of mood, anxiety, depression, and insomnia as well as in normal human functions such as sleep, sexual activity, and appetite. Thus, for medical chemists and pharmaceutical firms, serotonin is one of the most desirable targets. Among the seven different classes of serotonin receptors, the 5-HT
1A was one of the first discovered serotonin receptors, and the 5-HT7 was the last addition to the serotonin receptor family. Both the classes were thoroughly examined. 5-HT1A neurotransmission-related dysfunctions are linked to many psychological conditions such as anxiety, depression, and movement disorders. 5-HT7 is a member of the cell surface receptor GPCR superfamily and is regulated by the serotonin neurotransmitter. It has been the focus of intensive research efforts since its discovery, which was prompted by its presence in functionally important regions of the brain. The thalamus and hypothalamus have the highest 5-HT7 receptor densities. They are also found in the hippocampus and cortex at higher densities. Thermoregulation, circadian rhythm, learning and memory, and sleep are all associated with the 5-HT7 receptor. It is also suspected that this receptor may be involved in the control of mood, indicating that it may be a beneficial target for depression treatment. Several differently structured molecules such as aminotetralins, ergolines, arylpiperazines, indolylalkylamines, aporphines, and aryloxyalkyl-amines are known to bind to 5-HT1A and 5-HT7 receptor sites. In brain serotonin receptors 5-HT1A and 5-HT7 are strongly co-expressed in regions involved in depression. However, their functional interaction has not been identified. An overview of the 5-HT1A and 5-HT7 receptor ligands belonging to different chemical groups is mentioned in this review., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 Elsevier Inc. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
3. Synthesis, computational studies and preliminary pharmacological evaluation of 2-[4-(aryl substituted) piperazin-1-yl]-N-benzylacetamides as potential antipsychotics
- Author
-
Ranjit Singh, Amitabh Wahi, and Sushil Kumar
- Subjects
Serotonin ,Ketanserin ,Chemistry(all) ,Stereochemistry ,medicine.drug_class ,General Chemical Engineering ,Dopamine ,Atypical antipsychotic ,Catalepsy ,030226 pharmacology & pharmacy ,lcsh:Chemistry ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,medicine ,GeneralLiterature_REFERENCE(e.g.,dictionaries,encyclopedias,glossaries) ,ComputingMilieux_MISCELLANEOUS ,Clozapine ,Antipsychotic activity ,Risperidone ,Aryl ,General Chemistry ,medicine.disease ,030227 psychiatry ,Apomorphine ,Arylpiperazines ,N-benzylacetamide ,chemistry ,lcsh:QD1-999 ,Chemical Engineering(all) ,Antagonists ,Lead compound ,medicine.drug - Abstract
A series of 2-[4-(aryl substituted) piperazin-1-yl]- N -benzylacetamides were synthesized and the target compounds ( 3a–j ) were evaluated for atypical antipsychotic activity by studying apomorphine induced climbing behavior, 5-HTP induced head twitches behavior and catalepsy in mice. The physicochemical similarity of the target compounds with respect to standard drugs clozapine, ketanserin and risperidone was assessed by calculating from a set of physicochemical properties using software programs. The test compounds ( 3a–j ) demonstrated good similarity values with respect to the standard drugs. Among them, compound 3b has emerged as an important lead compound showing potential atypical antipsychotic-like profile.
- Published
- 2016
4. The mechanisms responsible for neuroprotective capacity of arylpiperazine dopaminergic ligands against cell death induced by sodium nitroprusside
- Author
-
Ignjatović, Đurđica S., Milutinovic, Danijela Vojnovic, Nikolić-Kokić, Aleksandra, Slavic, Marija, Andrić, Deana, Tomić, Mirko, Kostić Rajačić, Slađana, Ignjatović, Đurđica S., Milutinovic, Danijela Vojnovic, Nikolić-Kokić, Aleksandra, Slavic, Marija, Andrić, Deana, Tomić, Mirko, and Kostić Rajačić, Slađana
- Abstract
A group of sixteen arylpiperazines had been previously synthesized and evaluated for atypical antipsychotic activity. Here we examined these compounds for their neuroprotective capacity. The affinity and agonist/antagonist action of the arylpiperazines at dopamine hD(2S) receptors were determined in vitro on membranes from stably transfected CHO-hD(2S) cell line. The assays for cell viability and antioxidative capacity (total glutathione and total superoxide dismutase activity), amount of nitric oxide and superoxide radicals, as well as influence on prosurvival pathways (Akt and ERK), were performed on the human neuroblastoma cell line SH-SY5Y. Cell death was induced by oxidative or nitrosative stress, or by growing cells in the medium deprived of serum. Only four of the arylpiperazines exhibited notable neuroprotection against cell death induced by sodium nitroprusside. Two of these arylpiperazines induced elevations of pAkt, while two other compounds reduced the levels of pErk, whereas these actions are considered to support the cell survival. The benzimidazole heteroaryl-group, that mimics catechol moiety of the dopamine molecule, might be the prerequisite structure for the neuroprotective action of these ligands. It is postulated that neuroprotection was acquired also by elevation of endogenous glutathione or total superoxide dismutase activity.
- Published
- 2012
5. Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands
- Author
-
Laura López, Jana Selent, María Isabel Loza, Filipe Areias, Ferran Sanz, José Brea, Enrique Raviña, Manuel Pastor, Christian F. Masaguer, and Raquel Ortega
- Subjects
Lactams ,Stereochemistry ,Chemistry, Pharmaceutical ,Clinical Biochemistry ,Molecular Conformation ,Pharmaceutical Science ,Ligands ,Biochemistry ,Chemical synthesis ,Piperazines ,Dopamine receptor D1 ,Dopamine receptor D3 ,Drug Discovery ,Humans ,Structure–activity relationship ,Antipsychotics ,Receptor ,Dopamine receptors ,Molecular Biology ,Benzodiazepinones ,Molecular Structure ,Receptors, Dopamine D2 ,Chemistry ,Organic Chemistry ,Receptors, Dopamine D3 ,Ligand (biochemistry) ,Structure-activity relationship ,Affinities ,Arylpiperazines ,Kinetics ,Benzolactams ,Models, Chemical ,Dopamine receptor ,Drug Design ,Molecular Medicine ,Neurolèptics ,Dopamina -- Receptors ,Antipsychotic Agents - Abstract
A series of new benzolactam derivatives was synthesized and the derivatives were evaluated for their affinities at the dopamine D(1), D(2), and D(3) receptors. Some of these compounds showed high D(2) and/or D(3) affinity and selectivity over the D(1) receptor. The SAR study of these compounds revealed structural characteristics that decisively influenced their D(2) and D(3) affinities. Structural models of the complexes between some of the most representative compounds of this series and the D(2) and D(3) receptors were obtained with the aim of rationalizing the observed experimental results. Moreover, selected compounds showed moderate binding affinity on 5-HT(2A) which could contribute to reducing the occurrence of extrapyramidal side effects as potential antipsychotics.
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.